-transparent.png){kind=logo}
Carteolol was administered orally by gastric intubation at 3, 15, 75 or 150 mg/kg/day to ICR-JCL mice of both sexes prior to mating and to females during early stage of pregnancy to determine its effects on the entire reproductive process and fetal development. Following results were obtained: 1) The decrease of spontaneous motor activity was observed in all treatment groups, and some animals in the 75 mg/kg and 150 mg/kg groups pressed the chest or abdomen against the cage wall. 2) The incidence of early resorptions in the 75 mg/kg and 150 mg/kg groups was significantly higher than that in controls.3) The ossification of the talus and calcaneus was significantly retarded in the 75 mg/kg and 150 mg/kg groups. The maximum non-effective dose on fertility and reproduction for carteolol was estimated to be 15 mg/kg/day, although the incidence of early resorptions was slightly elevated with this dose.
N Tanaka, and
F Shingai, and
M Tamagawa, and
I Nakatsu
February 1979,
The Journal of toxicological sciences,
N Tanaka, and
F Shingai, and
M Tamagawa, and
I Nakatsu
May 1979,
Il Farmaco; edizione pratica,
N Tanaka, and
F Shingai, and
M Tamagawa, and
I Nakatsu
January 1990,
Obstetrical & gynecological survey,
N Tanaka, and
F Shingai, and
M Tamagawa, and
I Nakatsu
September 1997,
African journal of reproductive health,
N Tanaka, and
F Shingai, and
M Tamagawa, and
I Nakatsu
October 1989,
The Journal of toxicological sciences,
N Tanaka, and
F Shingai, and
M Tamagawa, and
I Nakatsu
January 1979,
Beitrage zur tropischen Landwirtschaft und Veterinarmedizin,
N Tanaka, and
F Shingai, and
M Tamagawa, and
I Nakatsu
October 1988,
Laboratory animal science,
N Tanaka, and
F Shingai, and
M Tamagawa, and
I Nakatsu
September 1972,
Arzneimittel-Forschung,
N Tanaka, and
F Shingai, and
M Tamagawa, and
I Nakatsu
January 2004,
International journal of toxicology,
N Tanaka, and
F Shingai, and
M Tamagawa, and
I Nakatsu
June 1994,
American journal of hospital pharmacy,
